CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 71 filers reported holding CHEMOCENTRYX INC in Q2 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,438,000 | +36.3% | 1,410,479 | +11.3% | 0.00% | 0.0% |
| Q3 2016 | $7,657,000 | +47.0% | 1,267,682 | +9.3% | 0.00% | +100.0% |
| Q2 2016 | $5,209,000 | +63.5% | 1,160,147 | -9.3% | 0.00% | 0.0% |
| Q1 2016 | $3,185,000 | -68.6% | 1,279,222 | +2.0% | 0.00% | -50.0% |
| Q4 2015 | $10,156,000 | +23.9% | 1,253,840 | -7.5% | 0.00% | 0.0% |
| Q3 2015 | $8,199,000 | -23.6% | 1,355,193 | +4.0% | 0.00% | -33.3% |
| Q2 2015 | $10,725,000 | +10.4% | 1,303,124 | +1.3% | 0.00% | +50.0% |
| Q1 2015 | $9,713,000 | +12.2% | 1,286,518 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $8,658,000 | +61.9% | 1,267,706 | +6.7% | 0.00% | 0.0% |
| Q3 2014 | $5,349,000 | -21.3% | 1,188,581 | +2.3% | 0.00% | 0.0% |
| Q2 2014 | $6,800,000 | -15.5% | 1,162,397 | -4.3% | 0.00% | 0.0% |
| Q1 2014 | $8,049,000 | +19.7% | 1,214,011 | +4.6% | 0.00% | 0.0% |
| Q4 2013 | $6,723,000 | +73.2% | 1,161,101 | +66.3% | 0.00% | +100.0% |
| Q3 2013 | $3,881,000 | -55.2% | 698,026 | +13.9% | 0.00% | -66.7% |
| Q2 2013 | $8,667,000 | – | 612,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
| Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
| Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
| WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
| Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
| A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
| BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |